ALNYLAM PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $120.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2014-02-20.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2014-02-20
- ALNYLAM PHARMACEUTICALS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2011 was $120.00K, a 45.45% decline from fiscal 2010.
- ALNYLAM PHARMACEUTICALS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2010 was $220.00K, a 50.11% decline from fiscal 2009.
- ALNYLAM PHARMACEUTICALS, INC. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2009 was $441.00K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2011-12-31 | $120.00K 10-K · filed 2014-02-20 |
| 2010-12-31 | $220.00K 10-K · filed 2013-02-19 |
| 2009-12-31 | $441.00K 10-K · filed 2012-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |